Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
332 studies found for:    glioblastoma | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
Condition: Adult Glioblastoma
Interventions: Radiation: Radiation;   Device: 3 Tesla magnetic resonance imaging;   Device: Chemical exchange saturation transfer MRI;   Device: Diffusion weighted MRI;   Device: Dynamic contrast enhancement MRI;   Device: Dynamic susceptibility contrast MRI
22 Recruiting Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
Condition: Glioblastoma
Intervention: Radiation: SRT to the resection cavity
23 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
24 Not yet recruiting Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Gliosarcoma;   Brain Neoplasms;   Central Nervous System Neoplasms
Interventions: Drug: topotecan;   Drug: pazopanib
25 Not yet recruiting Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
Conditions: Glioblastoma;   Glioblastoma Multiforme
Interventions: Drug: 5-day TMZ;   Drug: 21-day TMZ;   Biological: PEP-CMV;   Drug: Tetanus-Diphtheria booster;   Drug: Tetanus Pre-Conditioning
26 Unknown  Biomarkers for Prognosis of Glioblastoma (GBM)
Condition: Glioblastoma
27 Recruiting Surgery for Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Surgery followed by adjuvant second-line therapy;   Procedure: Second-line therapy alone
28 Recruiting A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily
29 Unknown  Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Conditions: Glioblastomas;   Gliosarcoma
Intervention: Other: Hyperbaric Oxygen Therapy
30 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia,;   Glioblastoma
Intervention: Drug: Romiplostim
31 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
32 Not yet recruiting uPAR-PET/MRI in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: One injection of 68Ga-NOTA-AE105;   Device: PET/MRI
33 Recruiting Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
Conditions: Glioblastoma;   Glioma
Intervention: Drug: Ribociclib
34 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
35 Recruiting O6-Benzylguanine and Temozolomide With MGMTP140K Genetically Modified Blood Stem Cells in Untreated Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Biological: MGMTP140K-encoding retroviral vector;   Drug: O6-benzylguanine;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Radiation: radiation therapy
36 Recruiting Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioblastoma
Conditions: Glioblastoma;   Astrocytoma
Intervention: Radiation: Rhenium Liposome Treatment
37 Recruiting Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Biological: anti-EGFRvIII CAR T cells;   Drug: cyclophosphamide;   Drug: Fludarabine
38 Recruiting Neoadjuvant Nivolumab in Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: Nivolumab
39 Unknown  Procarbazine and Lomustine in Recurrent Glioblastoma
Condition: Recurrent Glioblastoma Multiforme
Intervention: Drug: lomustine and procarbazine
40 Recruiting Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Biological: ALECSAT;   Radiation: radiotherapy;   Drug: Temozolomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years